Represented Global Pharmaceutical Manufacturer During Health Care Fraud Investigation

Client: A Pharmaceutical Manufacturer

Defended a foreign-based global pharmaceutical manufacturer in a multi-jurisdiction (federal and state) government investigation of sales, marketing, and research activities. Client was dismissed from the False Claims Act (FCA) qui tam action, and intervention proceeded against their co-promote partner only.